Mark Sabag - 04 Mar 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, International Markets
Signature
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
Issuer symbol
TEVA
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 15:11:14 UTC
Previous filing
02 Mar 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +15,920 +17% 110,523 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +43,358 +39% 153,881 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +23,764 +15% 177,645 05 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -15,920 -50% $0.000000 15,921 04 Mar 2022 Ordinary Shares 15,920 Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -43,358 -100% $0.000000* 0 04 Mar 2022 Ordinary Shares 43,358 Direct F1, F2, F4
transaction TEVA Restricted Share Units Award $0 +134,048 $0.000000 134,048 04 Mar 2022 Ordinary Shares 134,048 Direct F1, F2, F5
transaction TEVA Restricted Share Units Options Exercise $0 -23,764 -25% $0.000000 71,293 05 Mar 2022 Ordinary Shares 23,764 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 4, 2019, with 15,920 having vested on each of March 4, 2021 and March 4, 2022 and 15,921 vesting on March 4, 2023.
F4 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F5 Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
F6 Restricted share units were granted on March 5, 2021, with 23,764 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 23,765 vesting on March 5, 2025.